{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:59:48Z","timestamp":1790395188788,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fujian Provincial Science Fund for Distinguished Young Scholars","award":["2011J06015"],"award-info":[{"award-number":["2011J06015"]}]},{"name":"Fujian Provincial Fund for Key Platform of Scientific Innovation","award":["Grant no. 2014Y2101"],"award-info":[{"award-number":["Grant no. 2014Y2101"]}]},{"name":"Major National Project \u201c863\u201d","award":["Grant no. 2014AA021302"],"award-info":[{"award-number":["Grant no. 2014AA021302"]}]},{"name":"Xiamen Science and Technology Project","award":["3502Z201410045"],"award-info":[{"award-number":["3502Z201410045"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.coviro.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T14:45:21Z","timestamp":1429713921000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Lessons from hepatitis E vaccine design"],"prefix":"10.1016","volume":"11","author":[{"given":"Shaowei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2015.04.003_bib0290","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.003_bib0295","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(00)02737-9","article-title":"Duration of viraemia and faecal viral excretion in acute hepatitis E","volume":"356","author":"Aggarwal","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.003_bib0300","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","article-title":"Hepatitis E","volume":"367","author":"Hoofnagle","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.04.003_bib0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijgo.2003.11.018","article-title":"Hepatitis E in pregnancy","volume":"85","author":"Kumar","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.coviro.2015.04.003_bib0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00535-012-0682-0","article-title":"Culture systems for hepatitis E virus","volume":"48","author":"Okamoto","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0315","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.vaccine.2004.11.064","article-title":"A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates","volume":"23","author":"Li","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0320","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1074\/jbc.M410361200","article-title":"Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.04.003_bib0325","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4161\/hv.20042","article-title":"Hepatitis E vaccine development: a 14 year odyssey","volume":"8","author":"Wu","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coviro.2015.04.003_bib0330","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coviro.2015.04.003_bib0335","doi-asserted-by":"crossref","first-page":"33175","DOI":"10.1074\/jbc.M110.106336","article-title":"Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway","volume":"285","author":"Xing","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.04.003_bib0340","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JVI.02762-12","article-title":"Genetic variability and the classification of hepatitis E virus","volume":"87","author":"Smith","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0345","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/CMR.00062-13","article-title":"Host immune status and response to hepatitis E virus infection","volume":"27","author":"Krain","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2015.04.003_bib0350","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2165\/00003495-200464140-00002","article-title":"Hepatitis E vaccines: progress and prospects","volume":"64","author":"Worm","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.coviro.2015.04.003_bib0355","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1099\/vir.0.010561-0","article-title":"ORF3 protein of hepatitis E virus is essential for virion release from infected cells","volume":"90","author":"Yamada","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0360","doi-asserted-by":"crossref","first-page":"e1000537","DOI":"10.1371\/journal.ppat.1000537","article-title":"Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction","volume":"5","author":"Li","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0365","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1073\/pnas.0904848106","article-title":"Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding","volume":"106","author":"Guu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0370","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1073\/pnas.0903699106","article-title":"Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure","volume":"106","author":"Yamashita","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0375","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1073\/pnas.1101309108","article-title":"Structural basis for the neutralization and genotype specificity of hepatitis E virus","volume":"108","author":"Tang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0380","doi-asserted-by":"crossref","DOI":"10.1038\/cr.2015.34","article-title":"Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody","volume":"25","author":"Gu","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2015.04.003_bib0385","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/rmv.1719","article-title":"Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity","volume":"22","author":"Zhang","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0390","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1099\/vir.0.81545-0","article-title":"Putative neutralization epitopes and broad cross-genotype neutralization of hepatitis E virus confirmed by a quantitative cell-culture assay","volume":"87","author":"Emerson","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0395","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1128\/JVI.74.12.5548-5555.2000","article-title":"Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein","volume":"74","author":"Schofield","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0400","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2004.11.065","article-title":"Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein","volume":"23","author":"Zhang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_bib0405","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JVI.00657-10","article-title":"Spatial configuration of hepatitis E virus antigenic domain","volume":"85","author":"Xing","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1099\/vir.0.83308-0","article-title":"Putative receptor-binding sites of hepatitis E virus","volume":"89","author":"He","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0415","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.vaccine.2003.07.008","article-title":"Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine","volume":"22","author":"Schofield","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_bib0420","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1128\/JVI.74.17.8011-8017.2000","article-title":"Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies","volume":"74","author":"Riddell","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0425","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jmv.1027","article-title":"Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein","volume":"64","author":"Zhang","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0430","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cmi.2008.56","article-title":"The Leu477 and Leu613 of ORF2-encoded protein are critical in forming neutralization antigenic epitope of hepatitis E virus genotype 4","volume":"5","author":"Zhang","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.2001.1093","article-title":"Identification and characterization of the neutralization epitope(s) of the hepatitis E virus","volume":"288","author":"Meng","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.04.003_bib0440","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/viro.1994.1048","article-title":"Immunodominant antigenic regions in a structural protein of the hepatitis E virus","volume":"198","author":"Khudyakov Yu","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.04.003_bib0445","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JCM.37.9.2863-2871.1999","article-title":"Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus","volume":"37","author":"Khudyakov","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0450","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/vir.0.81393-0","article-title":"Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV","volume":"87","author":"Guo","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0455","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2893.2006.00796.x","article-title":"T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus","volume":"14","author":"Aggarwal","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2015.04.003_bib0460","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.molimm.2007.01.002","article-title":"Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity","volume":"44","author":"Wu","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0465","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<379::AID-JMV3>3.0.CO;2-X","article-title":"Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein","volume":"60","author":"Li","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0470","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/S0264-410X(01)00100-1","article-title":"A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus","volume":"19","author":"Im","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_bib0475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/viro.1999.0005","article-title":"Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopes","volume":"265","author":"Xing","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2015.04.003_bib0480","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1099\/vir.0.034835-0","article-title":"Characterization of self-assembled virus-like particles of rat hepatitis E virus generated by recombinant baculoviruses","volume":"92","author":"Li","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0485","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.vaccine.2014.02.025","article-title":"Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes","volume":"32","author":"Wei","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0490","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.coviro.2015.04.003_bib0495","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","article-title":"Virus-like particle-based human vaccines: quality assessment based on structural and functional properties","volume":"31","author":"Zhao","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0500","doi-asserted-by":"crossref","first-page":"22759","DOI":"10.1074\/jbc.M200185200","article-title":"The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2","volume":"277","author":"Tyagi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2015.04.003_bib0505","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3748\/wjg.v9.i10.2211","article-title":"Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products","volume":"9","author":"Ma","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0510","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/JCM.31.8.2167-2173.1993","article-title":"Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells","volume":"31","author":"He","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.70.1.207-216.1996","article-title":"Expression in animal cells and characterization of the hepatitis E virus structural proteins","volume":"70","author":"Jameel","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0520","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.1128\/JVI.79.20.12999-13006.2005","article-title":"Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0525","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/JVI.71.10.7207-7213.1997","article-title":"Expression and self-assembly of empty virus-like particles of hepatitis E virus","volume":"71","author":"Li","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2015.04.003_bib0530","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/prep.1997.0817","article-title":"Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells","volume":"12","author":"Robinson","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.coviro.2015.04.003_bib0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virusres.2011.03.015","article-title":"Structure of hepatitis E viral particle","volume":"161","author":"Mori","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2015.04.003_bib0540","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.vaccine.2014.05.064","article-title":"Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin((R))","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_bib0545","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pro.2213","article-title":"Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts","volume":"22","author":"Yang","year":"2013","journal-title":"Protein Sci"},{"key":"10.1016\/j.coviro.2015.04.003_bib0550","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa061847","article-title":"Safety and efficacy of a recombinant hepatitis E vaccine","volume":"356","author":"Shrestha","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.04.003_bib0555","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.vaccine.2008.12.061","article-title":"Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0560","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2015.04.003_sbref0565","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","article-title":"Long-term efficacy of a hepatitis E vaccine","volume":"372","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2015.04.003_bib0570","doi-asserted-by":"crossref","first-page":"O397","DOI":"10.1111\/1469-0691.12419","article-title":"Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity","volume":"20","author":"Zhang","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T01:51:42Z","timestamp":1598925102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962571500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":57,"alternative-id":["S187962571500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2015.04.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons from hepatitis E vaccine design","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}